Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,100 public trials 1,857 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors

NCT03386942

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Eisai Trial Site 5 Matsuyama, Ehime, Japan
  • Eisai Trial Site 6 Kurume, Fukuoka, Japan
  • Eisai Trial Site 8 Sapporo, Hokkaido, Japan
  • Eisai Trial Site 4 Akashi, Hyōgo, Japan
View Trial Details
Completed

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

NCT02857270

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 13 locations
View Trial Details
Completed

Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea

NCT03271554

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Inje University Busan Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
View all 37 locations
View Trial Details

Related conditions